Spots Global Cancer Trial Database for infiltrating urothelial carcinoma
Every month we try and update this database with for infiltrating urothelial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations | NCT02818725 | Infiltrating Ur... KRAS Gene Mutat... | Chemotherapy Panitumumab | 18 Years - | UNICANCER | |
| I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations | NCT02818725 | Infiltrating Ur... KRAS Gene Mutat... | Chemotherapy Panitumumab | 18 Years - | UNICANCER |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
